We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+11.8%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$3.57B
AUM Growth
+$263M
Cap. Flow
-$63.8M
Cap. Flow %
-1.79%
Top 10 Hldgs %
50.77%
Holding
72
New
2
Increased
42
Reduced
14
Closed
3

Top Buys

Rank Stock Value
1
CGNT icon
Cognyte Software
CGNT
+$11.5M
2
AZTA icon
Azenta
AZTA
+$8.85M
3
MEDP icon
Medpace
MEDP
+$8.43M
4
RBC icon
RBC Bearings
RBC
+$5.68M
5
VRNT
Verint Systems
VRNT
+$4.01M

Sector Composition

Rank Sector Weight
1 Technology 39.35%
2 Healthcare 35.28%
3 Industrials 15.84%
4 Financials 5.59%
5 Consumer Discretionary 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRNT icon
1
Kornit Digital
KRNT
$791M
$302M 8.44%
2,425,166
-2,639
-0.1% -$279K
IDXX icon
2
Idexx Laboratories
IDXX
$46.2B
$269M 7.53%
425,588
-1,786
-0.4% -$986K
FTNT icon
3
Fortinet
FTNT
$117B
$221M 6.19%
4,639,770
-53,575
-1% -$2.29M
MANH icon
4
Manhattan Associates
MANH
$11.4B
$195M 5.46%
1,347,009
+318
+0% +$42.4K
AVAV icon
5
AeroVironment
AVAV
$9.45B
$152M 4.26%
1,518,665
+1,886
+0.1% +$208K
ICLR icon
6
Icon
ICLR
$12.7B
$150M 4.19%
724,247
-74
-0% -$16K
RMD icon
7
ResMed
RMD
$30.7B
$143M 3.99%
578,220
-10,709
-2% -$2.25M
NICE icon
8
Nice
NICE
$5.97B
$134M 3.75%
541,191
+2,465
+0.5% +$568K
CGNX icon
9
Cognex
CGNX
$11.3B
$131M 3.67%
1,561,213
+3,123
+0.2% +$253K
ILMN icon
10
Illumina
ILMN
$28.4B
$117M 3.28%
254,402
+1,813
+0.7% +$730K
CYBR
11
DELISTED
CyberArk
CYBR
$110M 3.09%
846,167
+26,003
+3% +$3.46M
VEEV icon
12
Veeva Systems
VEEV
$37.4B
$106M 2.98%
341,774
+2,188
+0.6% +$610K
ANSS
13
DELISTED
Ansys
ANSS
$102M 2.86%
294,357
+3,032
+1% +$1.05M
TECH icon
14
Bio-Techne
TECH
$11.3B
$85.6M 2.4%
760,732
+10,344
+1% +$1.09M
FDS icon
15
Factset
FDS
$10.2B
$85M 2.38%
253,171
-81
-0% -$26.5K
JKHY icon
16
Jack Henry & Associates
JKHY
$11.1B
$73.4M 2.06%
449,010
+16,286
+4% +$2.6M
ABMD
17
DELISTED
Abiomed Inc
ABMD
$72.6M 2.03%
232,652
+11,413
+5% +$3.5M
VRNT
18
DELISTED
Verint Systems
VRNT
$69.1M 1.94%
1,534,147
+86,421
+6% +$4.01M
CRL icon
19
Charles River Laboratories
CRL
$12.8B
$64.9M 1.82%
175,500
QLYS icon
20
Qualys
QLYS
$6.35B
$64.6M 1.81%
641,356
+1,706
+0.3% +$174K
MEDP icon
21
Medpace
MEDP
$16.5B
$63.2M 1.77%
357,580
+48,830
+16% +$8.43M
CSGP icon
22
CoStar Group
CSGP
$12.3B
$59M 1.65%
711,964
+4,054
+0.6% +$350K
CGNT icon
23
Cognyte Software
CGNT
$680M
$57.6M 1.61%
2,352,737
+466,197
+25% +$11.5M
GNTX icon
24
Gentex
GNTX
$5.07B
$55.9M 1.56%
1,688,401
+82,240
+5% +$2.85M
MORN icon
25
Morningstar
MORN
$7.53B
$49.4M 1.38%
192,325
+150
+0.1% +$36.4K

Similar funds

American Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, American Capital Management held 72 positions worth $3.57B, up 8% from $3.31B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

American Capital Management's Q2 2021 filing shows 2 new, 42 increased, 14 reduced and 3 closed positions. Its largest new stake was Azenta: 91,210 shares worth $8.69M. The largest sale was RealPage, Inc., an estimated $53.9M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q2 2021 buy was Azenta: 91,210 shares worth $8.69M.
  • American Capital Management added most to Cognyte Software in Q2 2021, an estimated $11.5M increase.
  • American Capital Management's biggest Q2 2021 reduction was Proofpoint, Inc., cutting an estimated $23.8M.
  • American Capital Management fully exited RealPage, Inc. in Q2 2021, selling an estimated $53.9M.
  • American Capital Management's ten largest holdings make up 51% of its $3.57B portfolio in Q2 2021.
  • American Capital Management opened 2 new positions and closed 3 in Q2 2021.
  • American Capital Management's portfolio value rose 8% quarter-over-quarter to $3.57B.

Based on American Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.